Representative before the EPO

Employment test 501 - 1000 employees
Company dna olswang llp
operating since 1981
1170.85
Headquarter in London and 9 offices
active in Legal Services and IP Consulting

Representative before the EPO

Company dna cms cameron mckenna nabarro olswang llp
no operation time available
1 office
active in Legal Services

We have observed 85 EP applications Robert John Stephen has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 06, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11850571

SYSTEMS AND METHODS FOR AUTONOMOUS INTRAVENOUS NEEDLE INSERTION

IPC classification:
A61B 19/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP11850791

SYSTEMS AND METHODS FOR TREATING CONDITIONS AND DISEASES OF THE SPINE

IPC classification:
A61B 17/66
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP12713278

DIFFUSER AUGMENTED WIND TURBINES

IPC classification:
F03D 1/04, F03D 1/02
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP12712129

NON-SELF T-CELL EPITOPE FUSED TO AN ANTIBODY THAT RECOGNISES A TUMOUR-SPECIFIC CELL-SURFACE RECEPTOR AND USES THEREOF

IPC classification:
A61K 39/385
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12711420

METHODS FOR TREATING BACTERIAL INFECTION

IPC classification:
A61L 26/00, A61K 45/06, A61K 38/39, A61K 31/7036, A61K 31/5383, A61K 9/00, A61P 31/04, A61P 31/02, A61P 17/02
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Agent:
Donal Morgan Kelly, F. R. Kelly & Co.
Status:
GRANT OF PATENT INTENDED
EP12796397

USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION

IPC classification:
A61K 38/17, C07K 14/47, A61P 31/10
Agent:
Cooley (UK) LLP
Agent:
Robert John Stephen, Olswang
Status:
The patent has been granted
EP12716579

DIFFUSER AUGMENTED WIND TURBINES

IPC classification:
F03D 1/06, F03D 1/04, F03D 1/02
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP12811916

PARENTERAL NOROVIRUS VACCINE FORMULATIONS

IPC classification:
A61K 39/125
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
The patent has been granted
EP12827382

TRANSFORMATION OF JUVENILE AND MATURE CITRUS

IPC classification:
A01H 5/00, C12N 15/87, C12N 15/82
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP12834435

SYSTEMS AND METHODS FOR VISUALIZING ABLATED TISSUE

IPC classification:
A61B 1/06
Applicant:
The George Washington University
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13162799

A collagen powder

IPC classification:
C08L 89/06, C08J 3/12, C08H 1/06
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Agent:
Donal Morgan Kelly, F. R. Kelly & Co.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12867198

IMBIBING PROCESS FOR CONTACT LENS SURFACE MODIFICATION

IPC classification:
G02C 7/04, C08J 7/12, C08J 5/00, C08G 77/38, C08F 20/10
Agent:
Robert John Stephen, Olswang
Status:
APPLICATION WITHDRAWN
EP12856710

SURFACE MODIFICATION FOR DIALYSIS CATHETERS

IPC classification:
A61M 25/01, A61L 29/12, A61L 29/04
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP12857421

MULTISTEP UV PROCESS TO CREATE SURFACE MODIFIED CONTACT LENSES

IPC classification:
G02C 7/04, C08J 7/18, C08J 7/16, C08G 77/00, C08F 20/10
Agent:
Robert John Stephen, Olswang
Status:
APPLICATION WITHDRAWN
EP12856998

HIGH IONIC STRENGTH PROCESS FOR CONTACT LENS MODIFICATION

IPC classification:
G02C 7/04, C08J 7/16, C08J 5/00, C08G 77/38, C08F 20/10
Agent:
Robert John Stephen, Olswang
Status:
APPLICATION WITHDRAWN
EP12857659

LUMINAL MODIFICATIONS FOR CATHETERS

IPC classification:
A61M 25/01, A61L 29/12, A61L 29/04
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
The patent has been granted
EP12857366

REDOX PROCESSES FOR CONTACT LENS MODIFICATION

IPC classification:
G02C 7/04, C08J 7/16, C08J 5/00, C08G 77/38, C08F 20/10
Agent:
Robert John Stephen, Olswang
Status:
APPLICATION WITHDRAWN
EP12857271

SURFACE MODIFIED CONTACT LENSES

IPC classification:
G02C 7/04, C09D 133/04, C08J 7/04, C08F 20/10
Agent:
Robert John Stephen, Olswang
Status:
APPLICATION WITHDRAWN
EP12859572

A SYSTEM AND METHOD FOR EXTRACTION AND REFINING OF TITANIUM

IPC classification:
C22B 34/12, C22B 3/02
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP14170196

Animal models and therapeutic molecules

IPC classification:
A01K 67/027, C12N 15/90, C12N 15/85, C07K 16/46, C07K 16/00
Applicant:
Kymab Ltd
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
PATENT GRANTED
EP13746979

INNATE IMMUNE PROTEINS AS BIOMARKERS FOR CNS INJURY

IPC classification:
G01N 33/53
Applicant:
University of Miami
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
PATENT GRANTED
EP12857916

SURFACE MODIFICATION FOR CATHETERS COMPRISED OF MULTIPLE MATERIALS

IPC classification:
A61M 25/01, A61L 29/12, A61L 29/04
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP12857047

SILICONE HYDROGEL CONTACT LENS MODIFIED USING LANTHANIDE OR TRANSITION METAL OXIDANTS

IPC classification:
G02C 7/04, C08J 7/16, C08J 5/00, C08G 77/38, C08F 20/10
Agent:
Robert John Stephen, Olswang
Status:
APPLICATION WITHDRAWN
EP12826427

FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

IPC classification:
A61M 31/00, A61K 38/28, A61K 38/26, A61K 38/22, A61K 38/17, A61K 9/00
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP14171659

Imaging and evaluating embryos, oocytes, and stem cells

IPC classification:
G06T 7/20, G06T 7/00, G06K 9/00, G01N 33/68, C12N 5/073
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP12817417

APPARATUS AND METHODS FOR DETECTING ANALYTES

IPC classification:
G01N 33/543, G01N 33/53, C12Q 1/70, B01L 3/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP13778577

COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS

IPC classification:
A61K 47/38, A61K 31/23, A61K 31/195, A61K 9/06, A61P 31/04, A61P 31/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13723937

METHODS OF QUANTIFYING OF NUCLEIC ACIDS CAPTURED ON A SOLID SUPPORT.

IPC classification:
C12Q 1/68
Applicant:
Oxford Gene Technology IP Limited
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13723000

USE OF VEGFR1 AS A BIOMARKER FOR PKN3 INHIBITOR ADMINISTRATION

IPC classification:
A61K 38/00, G01N 33/50
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Stratagem IPM Limited
Status:
EXAMINATION IN PROGRESS
EP14186673

Hard surface cleaning composition

IPC classification:
C11D 3/43, C11D 3/20, C11D 1/75
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP13793204

SYSTEMS FOR TREATING PULMONARY INFECTIONS

IPC classification:
A61K 31/7036, A61K 31/7024, A61K 9/127, A61P 11/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP14186674

Hard surface cleaning composition

IPC classification:
C11D 3/43, C11D 3/20, C11D 1/75
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13794086

VISION ASSISTIVE DEVICES AND USER INTERFACES

IPC classification:
H04N 5/222
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP13752658

METHOD AND SYSTEM FOR PROVIDING GAMBLING GAMES

IPC classification:
G07F 17/32, A63F 13/30
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13834856

METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS

IPC classification:
A61K 48/00, A61K 38/02, A61K 31/195, C12N 15/63, C12N 5/10, C12N 5/071, A61P 25/28
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13844258

GENETIC MARKERS ASSOCIATED WITH ASD AND OTHER CHILDHOOD DEVELOPMENTAL DELAY DISORDERS

IPC classification:
C12Q 1/68, C12N 15/11
Agent:
Cooley (UK) LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13853777

METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS

IPC classification:
A61K 9/16, A61P 27/02
Agent:
Cooley (UK) LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13859435

PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME

IPC classification:
A61K 9/14
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP13858844

STABILIZED VANCOMYCIN FORMULATIONS

IPC classification:
A61K 31/70, A61K 9/127, A61P 11/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP13863937

DISTAL TIP FOR BONE FIXATION DEVICES

IPC classification:
A61M 29/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP15173932

DRY POWDER INHALER FORMULATIONS COMPRISING SURFACE-MODIFIED PARTICLES WITH ANTI-ADHERENT ADDITIVES

IPC classification:
A61K 9/14, A61K 9/12
Applicant:
Vectura Ltd
Agent:
Richard John Summersell, Vectura Ltd
Agent:
Robert John Stephen, Olswang
Status:
PATENT GRANTED
EP15175058

DESIGNER OSTEOGENIC PROTEINS

IPC classification:
A61K 38/18, C07K 14/51
Applicant:
Wyeth LLC
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
The patent has been granted
EP14746042

MEASURING EMBRYO DEVELOPMENT AND IMPLANTATION POTENTIAL WITH TIMING AND FIRST CYTOKINESIS PHENOTYPE PARAMETERS

IPC classification:
G01N 33/48
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP14745876

ABNORMAL SYNGAMY PHENOTYPES OBSERVED WITH TIME LAPSE IMAGING FOR EARLY IDENTIFICATION OF EMBRYOS WITH LOWER DEVELOPMENTAL POTENTIAL

IPC classification:
A61D 7/00, A61B 17/43
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP14728276

NOVEL FUNCTIONALIZED 4-(PHENOXYMETHYL(-1,3-DIOXOLANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USE

IPC classification:
C07D 409/14, C07D 407/14, C07D 407/06, C07D 413/14, A61P 25/00, A61K 31/495
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP14752057

LIGAND BINDING MOLECULES AND USES THEREOF

IPC classification:
A61P 27/02, A61P 9/14, A61K 38/18, A61K 31/711, C12N 15/86, C12N 15/85, C12N 15/12, C12N 15/63, C07K 19/00, C07K 14/475
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14751025

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI

IPC classification:
A61K 35/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14756365

APPARATUS, METHOD, AND SYSTEM FOR AUTOMATED, NON-INVASIVE CELL ACTIVITY TRACKING

IPC classification:
A61B 17/435
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14757061

APPARATUS, METHOD, AND SYSTEM FOR IMAGE-BASED HUMAN EMBRYO CELL CLASSIFICATION

IPC classification:
G06K 9/00, G01N 33/48, G01N 33/50
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP15188522

USE OF FERTILE TRANSGENIC ANIMALS FOR PRODUCING ANTIBODIES BEARING HUMAN VARIABLE REGIONS

IPC classification:
C07K 16/00, C12N 9/64, C12N 15/85, A01K 67/027
Applicant:
Kymab Ltd
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP15179144

LIPID COMPLEXES COATED WITH PEG AND THEIR USES

IPC classification:
A61K 48/00, A61K 31/713, A61K 47/48
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Stratagem IPM Limited
Status:
EXAMINATION REQUESTED
EP14731098

BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION (AMD)

IPC classification:
G01N 33/68
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Multiple attorneys, Olswang
Status:
EXAMINATION IN PROGRESS
EP14798157

PHOSPHORIC ACID/PHOSPHONIC ACID DERIVATIVES AND MEDICINAL USES THEREOF

IPC classification:
A61P 31/14, A61K 31/661, C07H 19/207, C07H 19/10, C07F 9/40
Applicant:
Nanjing Cavendish Bio-Engineering Technology Co., Ltd.
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14730966

WINE THERMOMETER

IPC classification:
G01K 1/14
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP14729863

SEMI-LIVE RESPIRATORY SYNCYTIAL VIRUS VACCINE

IPC classification:
A61K 39/00, C12N 5/10, A61K 39/155, C12N 7/00, C12N 15/86
Agent:
D Young & Co LLP
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP14729593

SEMI-LIVE RESPIRATORY SYNCYTIAL VIRUS VACCINE

IPC classification:
C12N 5/10, A61K 39/155, C12N 7/00, C12N 15/86
Agent:
D Young & Co LLP
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP14827034

LOW RESISTANCE AEROSOL EXHALATION FILTER

IPC classification:
A61M 15/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP16151214

ANIMAL MODELS AND THERAPEUTIC MOLECULES

IPC classification:
C12N 15/90, C12N 15/85, C07K 16/46, C07K 16/00, A01K 67/027
Applicant:
Kymab Ltd
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
The patent has been granted
EP16151215

ANIMAL MODELS AND THERAPEUTIC MOLECULES

IPC classification:
C12N 15/90, C12N 15/85, C07K 16/46, C07K 16/00, A01K 67/027
Applicant:
Kymab Ltd
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
The patent has been granted
EP14834012

ANTIMICROBIAL CATHETERS WITH PERMEABILIZATION AGENTS

IPC classification:
A61M 25/16
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP15184332

MODIFIED RELEASE COMPOSITIONS OF EPALRESTAT OR A DERIVATIVE THEREOF AND METHODS FOR USING THE SAME

IPC classification:
A61K 9/28, A61K 9/20, A61K 9/24, A61K 9/16, A61P 3/10, A61P 25/00, A61K 31/426
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14772197

EXPRESSION VECTOR PRODUCTION AND HIGH-THROUGHPUT CELL SCREENING

IPC classification:
C12N 15/09
Applicant:
Kymab Ltd
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP14847772

NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITNG CYTOCHROME P450 INHIBITION

IPC classification:
C07D 407/06, A61K 31/495
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP15198773

INTRAGASTRIC SPACE FILLER

IPC classification:
A61F 5/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP14852021

SYSTEM FOR AND METHOD OF PERFORMING SONASURGERY

IPC classification:
A61M 39/02, A61B 17/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
GRANT OF PATENT INTENDED
EP12736674

MODIFIED RELEASE COMPOSITIONS OF EPALRESTAT OR A DERIVATIVE THEREOF AND METHODS FOR USING THE SAME

IPC classification:
A61K 9/28, A61K 9/20, A61K 9/24, A61K 9/16, A61P 3/10, A61P 25/00, A61K 31/426
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14851897

FOCUSED ULTRASOUND TREATMENT USING FLUID BLADDER

IPC classification:
A61B 18/00, A61B 8/00, A61N 7/02, A61N 7/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14856188

PRODUCTION OF RECOMBINANT LUBRICIN

IPC classification:
C07K 14/47
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14747243

BREEDING, PRODUCTION, PROCESSING AND USE OF SPECIALTY CANNABIS

IPC classification:
C12N 15/82, A01H 5/00
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION IN PROGRESS
EP16156100

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS

IPC classification:
A61K 31/496, A61K 31/7048, A61K 31/7036, A61K 45/06, A61K 9/127, A61K 31/7034, A61K 9/00, A01N 61/00, A61K 9/14
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP16156099

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS

IPC classification:
A61K 31/496, A61K 31/7048, A61K 31/7036, A61K 45/06, A61K 9/127, A61K 31/7034, A61K 9/00, A01N 61/00, A61K 9/14
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14866058

COMPOSITIONS AND METHODS FOR INHIBITING INTERCELLULAR INTERACTIONS

IPC classification:
A61K 31/715
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP14824361

MEANS FOR LUNG SPECIFIC DELIVERY

IPC classification:
C12N 15/11, A61K 9/127
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Stratagem IPM Limited
Status:
EXAMINATION REQUESTED
EP16171392

INHIBITION OF THE TUMORIGENIC POTENTIAL OF TUMOR STEM CELLS BY LIF

IPC classification:
A61P 35/00, A61K 38/20, A61K 38/18
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
Request for examination was made
EP15736024

A CAMPING TABLE

IPC classification:
A47B 37/04, A47B 13/08, A47B 3/06, A01M 31/00, A47B 3/04
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
EXAMINATION REQUESTED
EP16183882

INTRAGASTRIC SPACE FILLER

IPC classification:
A61F 5/00, A61F 2/04
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Robert John Stephen, Olswang
Status:
Request for examination was made
EP16194336

CAP WITH FILTER AND TRANSFER APPARATUS

IPC classification:
B01L 3/00, C12M 1/00, C12M 1/24
Agent:
Robert John Stephen, Olswang
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
The patent has been granted
EP16197312

HIGH DELIVERY RATES FOR LIPID BASED DRUG FORMULATIONS, AND METHODS OF TREATMENT THEREOF

IPC classification:
A61P 11/00, A61K 9/72, A61K 9/127
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
Request for examination was made
EP15778328

INHALATION DEVICE FOR USE IN AEROSOL THERAPY OF RESPIRATORY DISEASES

IPC classification:
A61M 16/00, A61M 16/20, A61M 15/06, A61M 15/02, A61M 15/00, A61M 11/04, A61M 11/00
Applicant:
Vectura GmbH
Applicant:
Ablynx N.V.
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
Request for examination was made
EP15781619

METHODS OF TREATING RSV INFECTIONS

IPC classification:
A61M 15/06, A61P 11/00, A61M 16/20, A61M 16/00, A61M 15/02, A61M 11/04, A61M 15/00, A61M 11/00, A61K 47/26, A61K 9/00, A61K 47/10, A61K 39/395
Applicant:
Vectura GmbH
Applicant:
Ablynx N.V.
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
Request for examination was made
EP17170484

FURTHER NOVEL FORMS OF INTERFERING RNA MOLECULES

IPC classification:
C12N 5/10, A01K 67/027, C12Q 1/68, C07H 21/00, A61K 31/713, C12N 15/113
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
Request for examination was made
EP17170478

FURTHER NOVEL FORMS OF INTERFERING RNA MOLECULES

IPC classification:
C12N 5/10, A01K 67/027, C12Q 1/68, C07H 21/00, A61K 31/713, C12N 15/113
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
Request for examination was made
EP17160954

FURTHER NOVEL FORMS OF INTERFERING RNA MOLECULES

IPC classification:
C12N 5/10, A01K 67/027, C12Q 1/68, C07H 21/00, A61K 31/713, C12N 15/113
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
Request for examination was made
EP16163939

NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE

IPC classification:
A61P 1/16, A61K 31/7125, A61K 47/61
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
The application has been published
EP17174426

ANIMAL MODELS AND THERAPEUTIC MOLECULES

IPC classification:
C07K 16/18, C07K 16/12, C12N 15/90, C12N 15/85, C07K 16/46, C07K 16/00, A01K 67/027
Applicant:
Kymab Ltd
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
Request for examination was made

Please Sign in to use this feature